Advanced search
Publication Cover
Drug Delivery Volume 18, 2011 - Issue 7
Submit an article Journal homepage
1,246
Views
35
CrossRef citations to date
0
Altmetric
Research Article

Formulation of plumbagin loaded long circulating pegylated liposomes: in vivo evaluation in C57BL/6J mice bearing B16F1 melanoma

M. R. Sunil KumarDivision of Radiobiology and Toxicology, Manipal Life Sciences Centre, MU, Manipal, India
,
B. Kiran AithalDivision of Radiobiology and Toxicology, Manipal Life Sciences Centre, MU, Manipal, India
,
N. UdupaDepartment of Pharmaceutics, Manipal College of Pharmaceutical Sciences, MU, Manipal, India
,
M. Sreenivasulu ReddyDepartment of Anatomy, KMC International Centre, MU, Manipal, India
,
V. RaakeshDepartment of Anatomy, KMC International Centre, MU, Manipal, India
,
R.S.R. MurthyDepartment of Pharmaceutics, ISF College of Pharmacy, Moga, Punjab, India
,
D. Prudhvi RajuDepartment of Pharmacy, Centre of Relevance and Excellence in New Drug Delivery Systems of TIFAC, The M. S. University of Baroda, Vadodara, India
&
B. S. Satish RaoDivision of Radiobiology and Toxicology, Manipal Life Sciences Centre, MU, Manipal, IndiaCorrespondence[email protected]
 show all
Pages 511-522 | Received 10 Nov 2010, Accepted 27 May 2011, Published online: 28 Jul 2011

Citations (35)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (5)

Intouch Sakpakdeejaroen, Sukrut Somani, Partha Laskar, Margaret Mullin & Christine Dufès. (2021) Regression of Melanoma Following Intravenous Injection of Plumbagin Entrapped in Transferrin-Conjugated, Lipid–Polymer Hybrid Nanoparticles. International Journal of Nanomedicine 16, pages 2615-2631.
Read now
Somayeh Taymouri, Shabnam Shahnamnia, Azadeh Mesripour & Jaleh Varshosaz. (2021) In vitro and in vivo evaluation of an ionic sensitive in situ gel containing nanotransfersomes for aripiprazole nasal delivery. Pharmaceutical Development and Technology 26:8, pages 867-879.
Read now
S. Rajalakshmi, Niraj Vyawahare, Atmaram Pawar, Paresh Mahaparale & Bothiraja Chellampillai. (2018) Current development in novel drug delivery systems of bioactive molecule plumbagin. Artificial Cells, Nanomedicine, and Biotechnology 46:sup1, pages 209-218.
Read now
Tongyuan Lin, Xia Huang, Yanyan Wang, Tingting Zhu, Qing Luo, Xiaoxiao Wang, Kai Zhou, Hao Cheng, Daiyin Peng & Weidong Chen. (2017) Long circulation nanostructured lipid carriers for gambogenic acid: formulation design, characterization, and pharmacokinetic. Xenobiotica 47:9, pages 793-799.
Read now
Mohammed Shafik El-Ridy, Soad Aly Yehia, Mahfouz Abd-El-Megeid Kassem, Dina Mahmoud Mostafa, Essam Amin Nasr & Marwa Hasanin Asfour. (2015) Niosomal encapsulation of ethambutol hydrochloride for increasing its efficacy and safety. Drug Delivery 22:1, pages 21-36.
Read now

Articles from other publishers (30)

Lanlan Fan, Zheng Wang & Dunyun Shi. (2023) Targeted nanoscale drug delivery systems for melanoma therapy. Journal of Drug Delivery Science and Technology 86, pages 104724.
Crossref
Muhammad Taher, Deny Susanti, Muhammad Salahuddin Haris, Aina Atiqah Rushdan, Riyanto Teguh Widodo, Yandi Syukri & Junaidi Khotib. (2023) PEGylated liposomes enhance the effect of cytotoxic drug: A review. Heliyon 9:3, pages e13823.
Crossref
Niyatee Thakor & Bhavyata Janathia. (2022) Plumbagin: A Potential Candidate for Future Research and Development. Current Pharmaceutical Biotechnology 23:15, pages 1800-1812.
Crossref
Lesly Carolina Penaloza Arias, David N. Huynh, Samuel Babity, Sylvie Marleau & Davide Brambilla. (2022) Optimization of a Liposomal DNase I Formulation with an Extended Circulating Half-Life. Molecular Pharmaceutics 19:6, pages 1906-1916.
Crossref
Qing Li, Hao Luo, Yuan-Yuan Luo, Wei Zhang, Huang-Ming Hong, Meng-Sheng Deng, Yang Wang, Bo Xu, Guan-Bin Song & Cheng-Xiong Xu. (2022) Plumbagin-loaded ZIF-90 nanoparticles suppress gastric cancer progression by targeting the YAP1 signaling. Chemical Engineering Journal 437, pages 135369.
Crossref
Pavan Ram KambleKarimunnisa Sameer Shaikh. (2021) Optimization and Evaluation of Self-nanoemulsifying Drug Delivery System for Enhanced Bioavailability of Plumbagin. Planta Medica 88:01, pages 79-90.
Crossref
Ehab M. B. Mahdy, Sherif F. El-Sharabasy & Maiada M. El-Dawayati. 2022. Nutraceuticals Production from Plant Cell Factory. Nutraceuticals Production from Plant Cell Factory 345 374 .
Neeraj Taneja, Aftab Alam, Ranjana S. Patnaik & Tannu Taneja. (2021) Unmasking the potential role of plant‐based medicine “Plumbagin” in oral cancer—A Novel Paradigm. Oral Science International 19:1, pages 3-18.
Crossref
Jing-yan Tian, Chang-liang Chi, Ge Bian, Dong Xing, Feng-jun Guo & Xiao-qing Wang. (2021) PSMA conjugated combinatorial liposomal formulation encapsulating genistein and plumbagin to induce apoptosis in prostate cancer cells. Colloids and Surfaces B: Biointerfaces 203, pages 111723.
Crossref
Zerrin Sezgin-Bayindir, Sonia Losada-Barreiro, Carlos Bravo-Díaz, Matej Sova, Julijana Kristl & Luciano Saso. (2021) Nanotechnology-Based Drug Delivery to Improve the Therapeutic Benefits of NRF2 Modulators in Cancer Therapy. Antioxidants 10:5, pages 685.
Crossref
Farshad Mirzavi, Mehdi Barati, Anvar Soleimani, Roghayyeh Vakili-Ghartavol, Mahmoud Reza Jaafari & Mohammad Soukhtanloo. (2021) A review on liposome-based therapeutic approaches against malignant melanoma. International Journal of Pharmaceutics 599, pages 120413.
Crossref
Bai Xiang & De-Ying Cao. 2021. Liposome-Based Drug Delivery Systems. Liposome-Based Drug Delivery Systems 25 35 .
Renjie Zhang, Zijian Wang, Wenjie You, Fengfang Zhou, Zicheng Guo, Kaiyu Qian, Yu Xiao & Xinghuan Wang. (2020) Suppressive effects of plumbagin on the growth of human bladder cancer cells via PI3K/AKT/mTOR signaling pathways and EMT. Cancer Cell International 20:1.
Crossref
Adrian Chrastina, John Welsh, Gaelle Rondeau, Parisa Abedinpour, Per Borgström & Véronique T. Baron. (2020) Plumbagin‐Serum Albumin Interaction: Spectral, Electrochemical, Structure‐Binding Analysis, Antiproliferative and Cell Signaling Aspects with Implications for Anticancer Therapy. ChemMedChem 15:14, pages 1338-1347.
Crossref
Jing Zhang, Xiang Li & Leaf Huang. (2020) Anticancer activities of phytoconstituents and their liposomal targeting strategies against tumor cells and the microenvironment. Advanced Drug Delivery Reviews 154-155, pages 245-273.
Crossref
Jacinta Oliveira Pinho, Mariana Matias & Maria Manuela Gaspar. (2019) Emergent Nanotechnological Strategies for Systemic Chemotherapy against Melanoma. Nanomaterials 9:10, pages 1455.
Crossref
Intouch Sakpakdeejaroen, Sukrut Somani, Partha Laskar, Margaret Mullin & Christine Dufès. (2019) Transferrin‐bearing liposomes entrapping plumbagin for targeted cancer therapy. Journal of Interdisciplinary Nanomedicine 4:2, pages 54-71.
Crossref
Nathasak Sinlikhitkul, Pisanu Toochinda, Luckhana Lawtrakul, Pranporn Kuropakornpong & Arunporn Itharat. (2018) Encapsulation of plumbagin using cyclodextrins to enhance plumbagin stability: computational simulation, preparation, characterization, and application. Journal of Inclusion Phenomena and Macrocyclic Chemistry 93:3-4, pages 229-243.
Crossref
. (2019) Liposome Delivery of Natural STAT3 Inhibitors for the Treatment of Cancer. Pharmaceutical Frontiers.
Crossref
Hemant Ramchandra Badwaik, Leena Kumari, Kartik Nakhate, Vinay Sagar Verma & Kalyani Sakure. 2019. Bioactive Natural Products. Bioactive Natural Products 415 460 .
Adrian Chrastina, Veronique T. Baron, Parisa Abedinpour, Gaelle Rondeau, John Welsh & Per Borgström. (2018) Plumbagin-Loaded Nanoemulsion Drug Delivery Formulation and Evaluation of Antiproliferative Effect on Prostate Cancer Cells. BioMed Research International 2018, pages 1-7.
Crossref
Gaelle Rondeau, Parisa Abedinpour, Adrian Chrastina, Jennifer Pelayo, Per Borgstrom & John Welsh. (2018) Differential gene expression induced by anti-cancer agent plumbagin is mediated by androgen receptor in prostate cancer cells. Scientific Reports 8:1.
Crossref
Bai Xiang & De-Ying Cao. 2017. Liposome-Based Drug Delivery Systems. Liposome-Based Drug Delivery Systems 1 11 .
Yuling Liu, Yuee Cai, Chengwei He, Meiwan Chen & Hui Li. (2017) Anticancer Properties and Pharmaceutical Applications of Plumbagin: A Review. The American Journal of Chinese Medicine 45:03, pages 423-441.
Crossref
Wiriyaporn Sumsakul, Tullayakorn Plengsuriyakarn & Kesara Na-Bangchang. (2016) Pharmacokinetics, toxicity, and cytochrome P450 modulatory activity of plumbagin. BMC Pharmacology and Toxicology 17:1.
Crossref
Wiriyaporn Sumsakul & Kesara Na-Bangchang. (2015) Permeability of plumbagin across human intestinal cell in vitro. Archives of Pharmacal Research 39:3, pages 380-389.
Crossref
Atmaram Pawar, Rabiya Patel, S. Arulmozhi & C. Bothiraja. (2016) d -α-Tocopheryl polyethylene glycol 1000 succinate conjugated folic acid nanomicelles: towards enhanced bioavailability, stability, safety, prolonged drug release and synergized anticancer effect of plumbagin . RSC Advances 6:81, pages 78106-78121.
Crossref
Pharkphoom Panichayupakaranant & Md Iftekhar Ahmad. 2016. Drug Discovery from Mother Nature. Drug Discovery from Mother Nature 229 246 .
Wiriyaporn Sumsakul, Tullayakorn Plengsuriyakarn, Wanna Chaijaroenkul, Vithoon Viyanant, Juntra Karbwang & Kesara Na-Bangchang. (2014) Antimalarial activity of plumbagin in vitro and in animal models. BMC Complementary and Alternative Medicine 14:1.
Crossref
Chellampillai BothirajaHarshad S Kapare, Atmaram P Pawar & Karimunnisa S Shaikh. (2013) Development of plumbagin-loaded phospholipid–Tween ® 80 mixed micelles: formulation, optimization, effect on breast cancer cells and human blood/serum compatibility testing . Therapeutic Delivery 4:10, pages 1247-1259.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.